Matching patients to clinical trials could be improved with an artificial intelligence (AI) solution that allows health systems to identify participants more quickly and easily, according to new research from…
Realyze Intelligence Collaborating with Leading Cancer Center to Gain Insight into Patient Phenotypic Data
Realyze Intelligence’s solution is now being used at Memorial Sloan Kettering Cancer Center’s Innovation Hub to unlock clinical data and improve cancer treatment.
UPMC Researchers Use Realyze Intelligence Technology to Improve Treatments for Early-Stage Breast Cancer Patients
Realyze Intelligence has partnered with renowned cancer researchers at UPMC Hillman Cancer Center on a clinical study that could lead to improved treatment options for certain patients.
Experts address how health systems should harness the power of AI in new CCM report available to download.
Health care leaders across the United States expect artificial intelligence (AI) to have an impact on the industry. But when and how exactly?
Leading health system UPMC has launched Realyze Intelligence, a company that uses artificial intelligence and natural language processing to identify precise patient populations with chronic diseases and cancer to ensure…